Everest Organics Appoints Two Independent Directors

Director Appointments:

Approved the appointment of Mr. Srikanth Reddy Kolli (DIN: 06760614) as Additional Director (Independent Category) for a first term of five consecutive years commencing August 14, 2026, subject to member approval.
Approved the appointment of Mr. Subroto Banerjee (DIN: 06933525) as Additional Director (Independent Category) for a first term of five consecutive years commencing August 14, 2026, subject to member approval.

Committee Re-constitution:

Reconstituted the following committees with immediate effect from August 14, 2026:

Audit Committee:

Nomination and Remuneration Committee:

Stakeholders Relationship Committee:

Corporate Social Responsibility Committee:

Other Approvals:

Approved the Board's Report along with its annexures for the Financial Year 2025-26, forming part of the 33rd Annual Report.
Approved the Notice convening the 33rd Annual General Meeting (AGM) to be held on Wednesday, September 30, 2026 at 12:00 Noon IST through Video Conferencing/Other Audio Visual Means.
Set the Register of Members and Share Transfer Books closure period from Saturday, September 26, 2026 to Wednesday, September 30, 2026 (both days inclusive) for the AGM.
Fixed Friday, September 25, 2026 as the Record Date/Cut-off Date for determining member eligibility to attend and vote at the AGM.
Set remote e-voting period from 9:00 a.m. IST on Sunday, September 27, 2026 to 5:00 p.m. IST on Tuesday, September 29, 2026.
Appointed Mr. Y. Ravi Prasada Reddy, Practicing Company Secretary, Proprietor of M/s. RPR & Associates, as Scrutinizer for the remote e-voting process and venue e-voting at the AGM.
Approved payment of sitting fees to Non-Executive Independent Directors solely for attending Meetings of the Board and its Committees, excluding attendance at General Meetings or approvals via Circular Resolutions.

Mr. Srikanth Reddy Kolli:

Age: 44 years
Qualifications: Associate Member of the Institute of Company Secretaries of India (since 2010)
Registered with the Independent Directors' Databank maintained by Indian Institute of Corporate Affairs
Experience: Over 15 years in corporate secretarial practice, corporate governance, and statutory/regulatory compliance under Companies Act, 2013 and SEBI (LODR) Regulations, 2015
Current Directorship: Independent Director of ITISH Business Solutions Limited (member of Audit Committee and other committees)
No relationship with other directors of the company
Not debarred from holding director office by any SEBI Order or authority

Mr. Subroto Banerjee:

Expertise: Pharma & Healthcare Strategy Leader with 38 years experience
Current Roles: President–Strategy & Founding Team at Restory Healthytech (India's first geriatric healthtech company); independent consultant since 2016 (GLG, Guidepoint, PE/VC advisory)
Past Roles: President at Strides Shasun (grew business from $7M to $32M, led 5 M&A deals); Director-Oncology at Dr. Reddy's (launched India's first biosimilar mAb); VP at DCA Imaging; Head-India at Dabur Pharma; DGM at Biological E; sales leadership at Criticare & Farmitalia Carlo Erba
Expertise Areas: Business strategy, P&L leadership, M&A, market access, oncology/biologics/critical care
Qualifications: B.Sc. (Physics, Honors) from Calcutta University
No relationship with other directors of the company
Not debarred from holding director office by any SEBI Order or authority

Both directors hold no directorships in other listed entities.